Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s Health Ministry Gets Authority Over SFDA

This article was originally published in PharmAsia News

Executive Summary

Drug regulation in China is now under the control of the country's Ministry of Health. The ministry took control of the State FDA, a move intended to improve the record of the agency that regulates pharmaceutical and food safety. The ministry also oversees China's hospitals and public health system. The State Council approved the change, which took effect immediately. The change means the ministry will be ultimate authority in matters of SFDA regulation, safety, policy and quality assessments. The move has its critics who are concerned about too much centralization leading to corruption and negligence. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel